Serotonergic action on dorsal striatal function

Parkinsonism and Related Disorders

Volumn 18, Issue SUPPL. 1, 2012, Pages

  Mathur, Brian N ^a   Lovinger, David M ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Synaptic plasticity, Dopamine, Glutamate, GABA, Parkinson's disease

Indexed keywords

4 AMINOBUTYRIC ACID; BRAIN MONOAMINE; DOPAMINE; DOPAMINE AUTORECEPTOR; LEVODOPA; SEROTONIN; SEROTONIN RECEPTOR;

4 AMINOBUTYRIC ACID RELEASE; ARTICLE; CELL FUNCTION; CELL STRUCTURE; CORPUS STRIATUM; DOPAMINE RELEASE; HUMAN; NERVE CELL MEMBRANE STEADY POTENTIAL; NEUROPATHOLOGY; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RECEPTOR BINDING; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM;

EID: 84859872345     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/s1353-8020(11)70040-2     Document Type: Article

References (20)

1. Gerfen CR, Surmeier DJ. Modulation of striatal projection systems by dopamine. Annu Rev Neurosci 2011;34:441-66.
2. Soghomonian JJ, Descarries L, Watkins KC. Serotonin innervation in adult rat neostriatum. II. Ultrastructural features: a radioautographic and immunocytochemical study. Brain Res 1989;481:67-86.
3. Bédard C, Wallman MJ, Pourcher E, Gould PV, Parent A, Parent M. Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea. Parkinsonism Relat Disord 2011;17:593-8.
4. Kish SJ, Tong J, Hornykiewicz O, Rajput A, Chang LJ, Guttman M, et al. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. Brain 2008;131:120-31.
5. Henderson J, Yiannikas C, Graham JS. Effect of ritanserin, a highly selective 5-HT2 receptor antagonist, on Parkinson's disease. Clin Exp Neurol 1992;29:277-82.
6. Mũnoz A, Carlsson T, Tronci E, Kirik D, Bj ̈ orklund A, Carta M. Serotonin neurondependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model. Exp Neurol 2009;219:298-307.
7. Ostock CY, Dupre KB, Jaunarajs KL, Walters H, George J, Krolewski D, et al. Role of the primary motor cortex in L-DOPA-induced dyskinesia and its modulation by 5-HT1A receptor stimulation. Neuropharmacology 2011;61:753-60.
8. Di Matteo V, Pierucci M, Esposito E, Crescimanno G, Benigno A, Di Giovanni G. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders. Prog Brain Res 2008;172:423-63.
9. Frechilla D, Cobreros A, Saldise L, Moratalla R, Insausti R, Luquin M, et al. Serotonin 5-HT(1A) receptor expression is selectively enhanced in the striosomal compartment of chronic parkinsonian monkeys. Synapse 2001;39:288-96.
10. Dupre KB, Ostock CY, Eskow Jaunarajs KL, Button T, Savage LM, Wolf W, et al. Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats. Exp Neurol 2011;229:288-99.
11. Mathur BN, Capik NA, Alvarez VA, Lovinger DM. Serotonin induces long-term depression at corticostriatal synapses. J Neurosci 2011;31:7402-11.
12. Bubser M, Backstrom JR, Sanders-Bush E, Roth BL, Deutch AY. Distribution of serotonin 5-HT(2A) receptors in afferents of the rat striatum. Synapse 2001;39: 297-304.
13. Blomeley C, Bracci E. Excitatory effects of serotonin on rat striatal cholinergic interneurones. J Physiol 2005;569(Pt 3):715-21.
14. Ansah TA, Ferguson MC, Nayyar T. The 5-HT(2A) Receptor Antagonist M100907 Produces Antiparkinsonian Effects and Decreases Striatal Glutamate. Front Syst Neurosci 2011;5:48.
15. Bonsi P, Cuomo D, Ding J, Sciamanna G, Ulrich S, Tscherter A, et al. Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors. Neuropsychopharmacology 2007;32:1840-54.
16. Blomeley CP, Bracci E. Serotonin excites fast-spiking interneurons in the striatum. Eur J Neurosci 2009;29:1604-14.
17. Abdallah L, Bonasera SJ, Hopf FW, O'Dell L, Giorgetti M, Jongsma M, et al. Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function. J Neurosci 2009;29:8156-65.
18. Lee JY, Jeon BS, Kim HJ, Park SS. Genetic variant of HTR2A associates with risk of impulse control and repetitive behaviors in Parkinson's disease. Parkinsonism Relat Disord 2011 Sep 5 [Epub ahead of print]. doi: 10.1016/j.parkreldis.2011.08.009.
19. 2 receptor subtypes functional regulation in cerebral cortex of unilateral rotenone lesioned Parkinson's rat model: Effect of serotonin, dopamine and norepinephrine. Parkinsonism Relat Disord 2011;17:255-9.
20. Jacobs BL, Fornal CA. Activity of serotonergic neurons in behaving animals. Neuropsychopharmacology 1999;21:9S-15S.